Should You Increase Warfarin from 2.5 mg with INR 1.75?
Yes, increase the warfarin dose—an INR of 1.75 is subtherapeutic for nearly all indications and leaves the patient at significant thromboembolic risk. 1
Immediate Action
- Increase the weekly warfarin dose by approximately 10–20% when the INR is 1.5–1.9 (subtherapeutic but not critically low). 1
- For a patient on 2.5 mg daily (17.5 mg weekly), a 10–20% increase translates to adding 1.75–3.5 mg per week—practically, this means increasing the daily dose to 2.75–3.0 mg or alternating 2.5 mg and 3.0 mg on different days. 1
- Recheck the INR in 3–7 days after the dose adjustment to confirm upward movement toward the therapeutic range (2.0–3.0 for most indications). 1
Why This INR Is Problematic
- The standard therapeutic INR range for atrial fibrillation, venous thromboembolism, and most mechanical heart valves is 2.0–3.0. 2
- An INR of 1.75 provides inadequate anticoagulation and substantially raises the risk of stroke, systemic embolism, or valve thrombosis in high-risk patients. 1
- Thromboembolic risk is greater when INR is <2.0 than the bleeding risk associated with INR values in the therapeutic range. 1
Dose-Adjustment Algorithm
For INR 1.5–1.9 (Your Patient)
- Increase the weekly warfarin dose by 10% if the INR is 1.5–1.9 and the patient has no recent medication changes or dietary shifts. 1
- If the INR remains <1.5 on repeat testing, increase the weekly dose by 20%. 1
For INR 1.1–1.4
- Increase the weekly warfarin dose by approximately 20% because the INR is critically subtherapeutic. 1
Monitoring After Adjustment
- Recheck INR 3–7 days after any dose change during the titration phase. 1
- Once the INR stabilizes in the therapeutic range (2.0–3.0) for at least 2 consecutive measurements, extend monitoring to 2–3 times per week for 1–2 weeks, then weekly for the first month, and finally monthly once stability is confirmed. 1
Investigate Potential Causes of Low INR
Before simply increasing the dose, identify and correct factors that may have lowered the INR: 1
- Medication non-adherence or missed doses—the most common cause of subtherapeutic INR. 3
- Increased dietary vitamin K intake (e.g., more green leafy vegetables, vitamin K supplements). 1
- New medications, especially enzyme inducers (e.g., rifampin, carbamazepine, phenytoin) that accelerate warfarin metabolism. 1
- Gastrointestinal losses (diarrhea, vomiting) that reduce warfarin absorption. 1
- Intercurrent illness (fever, infection) that may alter warfarin metabolism. 1
Special Considerations
Elderly Patients
- Patients over 65 years typically require lower maintenance doses (2–4 mg daily rather than 5 mg) due to increased warfarin sensitivity. 1
- A 2.5 mg daily dose is already at the lower end of usual maintenance dosing, suggesting this patient may have moderate warfarin sensitivity. 1
- However, elderly patients still need therapeutic INR levels—age does not justify accepting subtherapeutic anticoagulation. 1
High-Risk Indications (Mechanical Valves, Recurrent VTE)
- Patients with mechanical mitral valves or those requiring INR 2.5–3.5 face markedly elevated thromboembolic risk when INR is <2.0. 1
- In these high-risk patients, do not delay dose adjustment—prolonged subtherapeutic INR significantly increases the likelihood of valve thrombosis or systemic embolization. 1
Common Pitfalls to Avoid
- Do not wait for the INR to "drift up" on its own—subtherapeutic INR requires active dose adjustment. 1
- Do not make large, abrupt dose increases (e.g., doubling the dose)—incremental adjustments of 10–20% are safer and more predictable. 1
- Do not assume the patient is "stable" on 2.5 mg just because they have been on this dose for a while—INR stability requires therapeutic values, not just consistent dosing. 1
- Do not forget to recheck the INR within one week after any dose change—failure to monitor can lead to either persistent subtherapeutic anticoagulation or overcorrection. 1
Practical Example
For a patient on 2.5 mg daily (17.5 mg/week) with INR 1.75:
- 10% increase: 17.5 mg + 1.75 mg = 19.25 mg/week → give 2.75 mg daily or alternate 2.5 mg and 3.0 mg (e.g., 2.5 mg × 4 days + 3.0 mg × 3 days = 19.5 mg/week). 1
- Recheck INR in 5–7 days to confirm upward movement. 1
- If the INR reaches 2.0–3.0, continue the new dose and monitor weekly for the first month. 1